Convatec Group PLC

Board/Management Information • Jun 30, 2020

National Storage Mechanism | Additional information

RNS Number : 4447R

ConvaTec Group PLC

30 June 2020

Board Committee Changes

Reading, United Kingdom (30 June 2020) 

The Board of ConvaTec Group Plc ("ConvaTec" or "the Company") confirms that in light of recent changes to the Directors that it has reconstituted the Committees of the Board as set out below. All changes shall take effect on 1 September 2020.

Remuneration Committee

Brian May shall serve as Chair along with Regina Benjamin who is an existing member, and Rick Anderson shall be appointed as a new member. Margaret Ewing shall step down from the Committee.

Audit and Risk Committee

Margaret Ewing shall continue to serve as Chair along with Brian May who is an existing member, and Heather Mason shall be appointed as a new member.

Nomination Committee

John McAdam shall continue to serve as Chair along with Margaret Ewing and Rick Anderson who are existing members, and Regina Benjamin, Heather Mason and Brian May shall be appointed as new members.

This announcement is made in accordance with Listing Rule 9.6.11R(3).

Enquiries:

Analysts and Investors

Mark Reynolds, Director Investor Relations                                                                      +44 (0)7551 036 625

ir@convatec.com

Media

Buchanan: Charles Ryland/Chris Lane/Vicky Hayns                                                         +44 (0)207 466 5000  

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has established market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.  www.convatecgroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BOAUKVWRRSUNUAR